Global investigation of the aryl hydrocarbon receptor/CYP1A1 axis in psoriasis

被引：0
|
作者：
Dokht Ashoori, M. [1 ]
Hardman-Smart, J. [1 ]
Dawe, H. [1 ]
Tosi, I. [1 ]
Wincent, E. [2 ]
Barker, J. [1 ]
Smith, C. [1 ]
Di Meglio, P. [1 ]
机构：
[1] Kings Coll London, St Johns Inst Dermatol, London, England
[2] Karolinska Inst, Inst Environm Med, Stockholm, Sweden
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 186卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P56
引用
收藏
页码：E43 / E43
页数：1
相关论文
共 50 条
  • [1] An integrative approach for the investigation of the AHR/CYP1A1 axis in psoriasis
    Gallon, Richard
    Hayes, Christine
    Phelps, Rachel
    Brugieres, Laurence
    Colas, Chrystelle
    Muleris, Martine
    Wimmer, Katharina
    Burn, John
    Jackson, Michael S.
    Santibanez-Koref, Mauro
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (06) : E240 - E241
  • [2] Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanism
    El Gendy, Mohamed A. M.
    El-Kadi, Ayman U. S.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2010, 249 (01) : 55 - 64
  • [3] Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction
    Wong, JMY
    Okey, AB
    Harper, PA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (04) : 990 - 996
  • [4] The effects of resveratrol on CYP1A1 expression and aryl hydrocarbon receptor function in vitro
    Ciolino, HP
    Yeh, GC
    NUTRITION AND CANCER PREVENTION: NEW INSIGHTS INTO THE ROLE OF PHYTOCHEMICALS, 2001, 492 : 183 - 193
  • [5] Tanshinone Ia is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor
    Han, EH
    Kim, JY
    Oh, DH
    Shin, DW
    Cho, YN
    Woo, ER
    Jeong, HG
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 197 (03) : 212 - 212
  • [6] Concurrent expression of aryl hydrocarbon receptor and CYP1A1 but not CYP1A1 MspI polymorphism is correlated with gastric cancers raised in Dalian, China
    Ma, Jing-Xin
    Zhang, Kai-Li
    Liu, Xu
    Ma, Yan-Lu
    Pei, Li-Na
    Zhu, Yi-Fang
    Zhou, Lei
    Chen, Xiao-Yan
    Kong, Qing-You
    Li, Hong
    Liu, Jia
    CANCER LETTERS, 2006, 240 (02) : 253 - 260
  • [7] The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor
    H P Ciolino
    G C Yeh
    British Journal of Cancer, 1999, 79 : 1340 - 1346
  • [8] Cooperativity Between Aryl Hydrocarbon Receptor and β-catenin Binding Sites in CYP1A1 Induction
    Schulthess, P.
    Braeuning, A.
    Loeffler, A.
    Schwarz, M.
    Bluethgen, N.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S75 - S75
  • [9] Up-regulation of CYP1A1 by rutaecarpine is dependent on aryl hydrocarbon receptor and calcium
    Han, Eun Hee
    Kim, Hyung Gyun
    Im, Ji Hye
    Jeong, Tae Cheon
    Jeong, Hye Gwang
    TOXICOLOGY, 2009, 266 (1-3) : 38 - 47
  • [10] Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor
    Ciolino, HP
    Daschner, PJ
    Yeh, GC
    CANCER RESEARCH, 1998, 58 (24) : 5707 - 5712
12345